April D. Lake
About
April D. Lake is a scholar working on Epidemiology, Oncology and Hepatology.
According to data from OpenAlex, April D. Lake has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 10 papers in Oncology and 9 papers in Hepatology. Recurrent topics in April D. Lake's work include Liver Disease Diagnosis and Treatment (18 papers), Drug Transport and Resistance Mechanisms (10 papers) and Liver Diseases and Immunity (8 papers). April D. Lake is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Drug Transport and Resistance Mechanisms (10 papers) and Liver Diseases and Immunity (8 papers). April D. Lake collaborates with scholars based in United States, Czechia and Germany. April D. Lake's co-authors include Nathan J. Cherrington, Rhiannon N. Hardwick, Petr Novák, Mark J. Canet, John Clarke, Craig D. Fisher, Donald G. Robertson, Michael D. Reily, Petia Shipkova and Nelly Aranı́bar and has published in prestigious journals such as Journal of Hepatology, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.
In The Last Decade
April D. Lake
23 papers receiving 1.3k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| April D. Lake United States | 17 | 870 | 429 | 365 | 266 | 238 | 23 | 1.3k | ||
| Rhiannon N. Hardwick United States | 22 | 724 0.8× | 277 0.6× | 534 1.5× | 267 1.0× | 166 0.7× | 33 | 1.4k | ||
| Sayeepriyadarshini Anakk United States | 21 | 354 0.4× | 604 1.4× | 393 1.1× | 245 0.9× | 138 0.6× | 49 | 1.5k | ||
| Andrew J. Lickteig United States | 15 | 439 0.5× | 239 0.6× | 391 1.1× | 154 0.6× | 132 0.6× | 25 | 901 | ||
| Bingning Dong United States | 20 | 578 0.7× | 837 2.0× | 546 1.5× | 307 1.2× | 232 1.0× | 30 | 2.0k | ||
| Nelson Varela Chile | 17 | 464 0.5× | 535 1.2× | 157 0.4× | 109 0.4× | 233 1.0× | 59 | 1.3k | ||
| Kazuyoshi Kon Japan | 20 | 778 0.9× | 386 0.9× | 185 0.5× | 500 1.9× | 139 0.6× | 52 | 1.6k | ||
| Seiichiro Kamimura Japan | 16 | 677 0.8× | 396 0.9× | 99 0.3× | 283 1.1× | 164 0.7× | 45 | 1.6k | ||
| Meishu Xu United States | 25 | 354 0.4× | 518 1.2× | 268 0.7× | 137 0.5× | 259 1.1× | 50 | 1.4k | ||
| Tin Aung Than United States | 17 | 1.1k 1.3× | 599 1.4× | 183 0.5× | 561 2.1× | 377 1.6× | 26 | 2.1k | ||
| Kaili Fu China | 12 | 461 0.5× | 573 1.3× | 181 0.5× | 142 0.5× | 112 0.5× | 14 | 1.1k |
Countries citing papers authored by April D. Lake
Since
Specialization
Citations
This map shows the geographic impact of April D. Lake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April D. Lake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April D. Lake more than expected).
Fields of papers citing papers by April D. Lake
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by April D. Lake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April D. Lake. The network helps show where April D. Lake may publish in the future.
Co-authorship network of co-authors of April D. Lake
This figure shows the co-authorship network connecting the top 25 collaborators of April D. Lake. A scholar is included among the top collaborators of April D. Lake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with April D. Lake. April D. Lake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lake, April D., Joseph C. Arezzo, Ricardo Ramírez, et al.. (2022). Neurotoxicity of an Hepatitis B Virus (HBV) Transcript Inhibitor in 13-Week Rat and Monkey Studies. Toxicological Sciences. 186(2). 298–308.
2.
Lake, April D., Rhiannon N. Hardwick, Christopher P. Leamon, Philip S. Low, & Nathan J. Cherrington. (2019). Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis. Toxicology and Applied Pharmacology. 368. 49–54.
3.
Clarke, John, Petr Novák, April D. Lake, Rhiannon N. Hardwick, & Nathan J. Cherrington. (2017). Impaired N‐linked glycosylation of uptake and efflux transporters in human non‐alcoholic fatty liver disease. Liver International. 37(7). 1074–1081.
4.
Lake, April D., Charles E. Wood, Virunya S. Bhat, et al.. (2015). Dose and Effect Thresholds for Early Key Events in a PPARα-Mediated Mode of Action. Toxicological Sciences. 149(2). 312–325.
5.
Wood, Charles E., Susan Hester, Brian N. Chorley, et al.. (2015). Latent carcinogenicity of early-life exposure to dichloroacetic acid in mice. Carcinogenesis. 36(7). 782–791.
6.
Canet, Mark J., Rhiannon N. Hardwick, April D. Lake, et al.. (2014). Renal Xenobiotic Transporter Expression is Altered in Multiple Experimental Models of Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition. 43(2). 266–272.
7.
Hardwick, Rhiannon N., John Clarke, April D. Lake, et al.. (2014). Increased Susceptibility to Methotrexate-Induced Toxicity in Nonalcoholic Steatohepatitis. Toxicological Sciences. 142(1). 45–55.
8.
Clarke, John, Rhiannon N. Hardwick, April D. Lake, Mark J. Canet, & Nathan J. Cherrington. (2014). Experimental Nonalcoholic Steatohepatitis Increases Exposure to Simvastatin Hydroxy Acid by Decreasing Hepatic Organic Anion Transporting Polypeptide Expression. Journal of Pharmacology and Experimental Therapeutics. 348(3). 452–458.
9.
Clarke, John, Rhiannon N. Hardwick, April D. Lake, et al.. (2014). Synergistic interaction between genetics and disease on pravastatin disposition. Journal of Hepatology. 61(1). 139–147.
10.
Canet, Mark J., Rhiannon N. Hardwick, April D. Lake, et al.. (2014). Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models. Drug Metabolism and Disposition. 42(4). 586–595.
11.
Lake, April D., Petr Novák, Petia Shipkova, et al.. (2014). Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease. Amino Acids. 47(3). 603–615.
12.
Dzierlenga, Anika L., et al.. (2013). Differential Regulation of Hepatic Organic Cation Transporter 1, Organic Anion-Transporting Polypeptide 1a4, Bile-Salt Export Pump, and Multidrug Resistance-Associated Protein 2 Transporter Expression in Lymphocyte-Deficient Mice Associates with Interleukin-6 Production. Journal of Pharmacology and Experimental Therapeutics. 347(1). 136–144.
13.
Clarke, John, Petr Novák, April D. Lake, et al.. (2013). Characterization of Hepatocellular Carcinoma Related Genes and Metabolites in Human Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences. 59(2). 365–374.
14.
Lake, April D., Petr Novák, Petia Shipkova, et al.. (2013). Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease. Toxicology and Applied Pharmacology. 268(2). 132–140.
15.
Lake, April D., Petr Novák, Rhiannon N. Hardwick, et al.. (2013). The Adaptive Endoplasmic Reticulum Stress Response to Lipotoxicity in Progressive Human Nonalcoholic Fatty Liver Disease. Toxicological Sciences. 137(1). 26–35.
16.
Canet, Mark J., Rhiannon N. Hardwick, April D. Lake, et al.. (2012). Altered Arsenic Disposition in Experimental Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 40(9). 1817–1824.
17.
Hardwick, Rhiannon N., Vijay R. More, April D. Lake, et al.. (2012). Altered UDP-Glucuronosyltransferase and Sulfotransferase Expression and Function during Progressive Stages of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 41(3). 554–561.
18.
Lake, April D., Petr Novák, Craig D. Fisher, et al.. (2011). Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 39(10). 1954–1960.
19.
Zárate, Xristo, et al.. (2010). Development of high-yield autofluorescent protein microarrays using hybrid cell-free expression with combined Escherichia coli S30 and wheat germ extracts. Proteome Science. 8(1). 32–32.
20.
Hardwick, Rhiannon N., Craig D. Fisher, Mark J. Canet, April D. Lake, & Nathan J. Cherrington. (2010). Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 38(12). 2293–2301.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Rhiannon N. Hardwick Breakdown of academic impact, for papers by Sayeepriyadarshini Anakk Breakdown of academic impact, for papers by Andrew J. Lickteig Breakdown of academic impact, for papers by Bingning Dong Breakdown of academic impact, for papers by Nelson Varela Breakdown of academic impact, for papers by Kazuyoshi Kon Breakdown of academic impact, for papers by Seiichiro Kamimura Breakdown of academic impact, for papers by Meishu Xu Breakdown of academic impact, for papers by Tin Aung Than Breakdown of academic impact, for papers by Kaili Fu